World's Best Scientists 2026 revealed!

Peter van der Meer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter van der Meer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Peter van der Meer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter van der Meer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter van der Meer is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily lies within the field of Medicine, with a particular focus on Cardiology and Cardiovascular Medicine.

Their work spans several subfields, including Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, and Surgery. The main topics of their research cover areas related to heart and cardiovascular health, such as Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, and Chemotherapy-induced cardiotoxicity and mitigation. Additional topics include Cardiac pacing and defibrillation studies, Atrial Fibrillation Management and Outcomes, Cardiac Imaging and Diagnostics, and Diabetes Treatment and Management.

Peter van der Meer has contributed to a number of publications, including key papers such as:

  • Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC., 2021, PubMed
  • 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery, 2022, European Heart Journal
  • Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy, 2024, New England Journal of Medicine
  • Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), 2020, European Journal of Heart Failure
  • Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management, 2020, European Journal of Preventive Cardiology

The frequent co-authors of Peter van der Meer include Rudolf A. de Boer, Dirk J. van Veldhuisen, Marco Metra, Adriaan A. Voors, and B. Daan Westenbrink.

The scientist often publishes in specialized venues such as:

  • European Journal of Heart Failure
  • European Heart Journal
  • European Journal of Preventive Cardiology
  • ESC Heart Failure
  • JACC CardioOncology

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    Piotr Ponikowski;Adriaan A Voors;Stefan D Anker;Héctor Bueno

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • Anemia and Mortality in Heart Failure Patients: A Systematic Review and Meta-Analysis

    Hessel F. Groenveld;James L. Januzzi;Kevin Damman;Jan van Wijngaarden

  • Iron deficiency in chronic heart failure: an international pooled analysis.

    IJsbrand T. Klip;Josep Comin-Colet;Adriaan A. Voors;Piotr Ponikowski

  • Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

    Dirk J. A. Lok;Peter Van Der Meer;Pieta W. Bruggink-André de la Porte;Erik Lipsic

  • Treating oxidative stress in heart failure: past, present and future.

    Atze van der Pol;Atze van der Pol;Wiek H. van Gilst;Adriaan A. Voors;Peter van der Meer

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

    Piotr Ponikowski;Bridget-Anne Kirwan;Bridget-Anne Kirwan;Stefan D Anker;Theresa McDonagh;Theresa McDonagh

  • Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.

    Dirk J. van Veldhuisen;Piotr Ponikowski;Peter van der Meer;Marco Metra

  • Red blood cell distribution width and 1‐year mortality in acute heart failure

    Roland R. J. van Kimmenade;Asim A. Mohammed;Shanmugam Uthamalingam;Peter van der Meer;Peter van der Meer

  • Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial

    Elke S. Hoendermis;Licette C. Y. Liu;Yoran M. Hummel;Peter van der Meer

  • Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy

    Johann Bauersachs;Tobias König;Peter van der Meer;Mark C Petrie

  • Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial Infarction

    Peter van der Meer;Erik Lipsic;Robert H. Henning;Kristien Boddeus

  • Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension

    Praveen Surendran;Fotios Drenos;Robin Young;Helen Warren

  • MicroRNAs in heart failure: from biomarker to target for therapy

    Eline L. Vegter;Peter van der Meer;Leon J. de Windt;Yigal M. Pinto

  • Heart Failure Stimulates Tumor Growth by Circulating Factors

    Wouter C Meijers;Manuel Maglione;Stephan J L Bakker;Rupert Oberhuber

  • Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function

    Martijn F Hoes;Niels Grote Beverborg;J David Kijlstra;Jeroen Kuipers

  • Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

    B. Daan Westenbrink;Erik Lipsic;Peter van der Meer;Pirn van der Harst

  • Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council

    Patrizio Lancellotti;Thomas M Suter;Teresa López-Fernández;Maurizio Galderisi

  • Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

    Dirk J. Lok;Sjoukje I. Lok;Pieta W. Bruggink-André de la Porte;Erik Badings

  • Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis

    Beben Benyamin;Tonu Esko;Janina S. Ried;Aparna Radhakrishnan

Frequent Co-Authors

Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Rudolf A. de Boer
Rudolf A. de Boer University Medical Center Groningen
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University
John G.F. Cleland
John G.F. Cleland University of Glasgow
Pim van der Harst
Pim van der Harst University Medical Center Utrecht
Hans L. Hillege
Hans L. Hillege University Medical Center Groningen
Marco Metra
Marco Metra University of Brescia
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Kenneth Dickstein
Kenneth Dickstein University of Bergen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees can open doors to diverse healthcare careers in the USA, especially for those not pursuing a traditional MD path. For individuals without previous nursing experience, online bsn programs for non nurses provide a flexible entry into registered nursing, allowing you to study and qualify from anywhere.

If you are interested in healthcare administration or support roles, there are also healthcare administration degree programs offered online, which are designed for quick completion and career advancement.

Financial aid is often a critical factor. For students seeking affordable pathways, online medical billing and coding schools that accept fafsa can lower costs and grant access to in-demand medical coding careers.

Additionally, some nursing programs have more accessible admissions. If you’re aiming to become an LPN, finding out do I need to take the TEAS test for LPN can help you identify schools that have streamlined requirements, making your pathway into nursing even smoother.

Best Scientists Citing Peter van der Meer

Trending Scientists

Recently Published Articles